Metabolism and pharmacokinetic drug interaction profile of vericiguat, a soluble guanylate cyclase stimulator

被引：0
|
作者：
Lobmeyer, M. Maximilian [1 ]
Gerisch, M. [2 ]
Boettcher, M-F [1 ]
Thomas, D. [3 ]
Gerrits, M. [4 ]
Mueck, W. [1 ]
Besche, N. [5 ]
Becker, C. [1 ]
机构：
[1] Bayer AG, Clin Pharmacol, Wuppertal, Germany
[2] Bayer AG, DMPK, Wuppertal, Germany
[3] Bayer AG, Expt Med, Wuppertal, Germany
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Chrestos Concept GmbH & Co KG, Essen, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1706
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [1] Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies
    Michael Boettcher
    Michael Gerisch
    Maximilian Lobmeyer
    Nina Besche
    Dirk Thomas
    Mireille Gerrits
    Julia Lemmen
    Wolfgang Mueck
    Martin Radtke
    Corina Becker
    Clinical Pharmacokinetics, 2020, 59 : 1407 - 1418
  • [2] Metabolism and Pharmacokinetic Drug-Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies
    Boettcher, Michael
    Gerisch, Michael
    Lobmeyer, Maximilian
    Besche, Nina
    Thomas, Dirk
    Gerrits, Mireille
    Lemmen, Julia
    Mueck, Wolfgang
    Radtke, Martin
    Becker, Corina
    CLINICAL PHARMACOKINETICS, 2020, 59 (11) : 1407 - 1418
  • [3] Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro
    Rickert, Verena
    Haefeli, Walter Emil
    Weiss, Johanna
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (02) : 130 - 137
  • [4] Vericiguat - soluble guanylate cyclase stimulator, in therapy of heart failure
    Melenovsky, Vojtech
    COR ET VASA, 2022, 64 (03) : 316 - 319
  • [5] Nonclinical Cardiovascular Assessment of the Soluble Guanylate Cyclase Stimulator Vericiguat
    Himmel, Herbert
    Lagrutta, Armando
    Voemel, Matthias
    Amin, Rupesh P.
    Imredy, John P.
    Johnson, Timothy
    Vinzing, Maya
    Prescott, Judith
    Blaustein, Robert O.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 386 (01): : 26 - 34
  • [6] Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure
    Campbell, Nicole
    Kalabalik-Hoganson, Julie
    Frey, Kathleen
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 600 - 608
  • [7] Soluble guanylate cyclase (sGC) stimulator vericiguat as a potential treatment for heart failure
    Follmann, Markus
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [8] Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator for Use in Patients With Heart Failure
    Gupta, Rahul
    Lin, Muling
    Maitz, Theresa
    Egeler, David J. J.
    Sood, Aayaan
    Aronow, Wilbert S. S.
    Rajeswaran, Yasotha
    Ahnert, Amy M. M.
    Vyas, Apurva V. V.
    Frishman, William H. H.
    Lanier, Gregg M. M.
    CARDIOLOGY IN REVIEW, 2023, 31 (02) : 87 - 92
  • [9] Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
    Follmann, Markus
    Ackerstaff, Jens
    Redlich, Gorden
    Wunder, Frank
    Lang, Dieter
    Kern, Armin
    Fey, Peter
    Griebenow, Nils
    Kroh, Walter
    Becker-Pelster, Eva-Maria
    Kretschmer, Axel
    Geiss, Volker
    Li, Volkhart
    Straub, Alexander
    Mittendorf, Joachim
    Jautelat, Rolf
    Schirok, Hartmut
    Schlemmer, Karl-Heinz
    Lustig, Klemens
    Gerisch, Michael
    Knorr, Andreas
    Tine, Hanna
    Mondritzki, Thomas
    Truebel, Hubert
    Sandner, Peter
    Stasch, Johannes-Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (12) : 5146 - 5161
  • [10] Antihypertensive Effects of a Soluble Guanylate Cyclase Stimulator
    V. V. Bykov
    Yu. G. Birulina
    A. V. Nosarev
    A. I. Vengerovskii
    V. V. Udut
    Bulletin of Experimental Biology and Medicine, 2022, 174 : 33 - 36
12345